TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA Cash Flow

Teva pharmaceutical industries ltd (TEVA)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09	Dec'08	Sep'08	Jun'08	Mar'08
Operating activities:
Net income (loss)
25,000	76,000	-308,000	-671,000	-97,000	-3,243,000	-197,000	-166,000	1,134,000	-11,730,000	610,000	-5,970,000	641,000	-974,000	410,000	242,000	633,000	498,000	116,000	539,000	444,000	694,000	863,000	745,000	740,000	377,000	706,000	-456,000	626,000	280,000	-84,000	859,000	855,000	505,000	918,000	580,000	765,000	773,000	1,052,000	800,000	714,000	380,000	650,000	523,000	451,000	-692,000	635,000	533,000	139,000
Adjustments to reconcile net income (loss) to net cash provided by operations:
Acquisition of research and development in process
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	382,000
Depreciation and amortization
399,000	416,000	413,000	450,000	443,000	382,000	474,000	479,000	507,000	528,000	527,000	577,000	480,000	332,000	577,000	310,000	305,000	335,000	315,000	323,000	335,000	369,000	361,000	374,000	404,000	436,000	419,000	400,000	387,000	393,000	412,000	384,000	519,000	332,000	247,000	224,000	266,000	250,000	259,000	233,000	235,000	240,000	254,000	257,000	157,000	117,000	127,000	169,000	77,000
Impairment of long-lived assets
724,000	476,000	205,000	608,000	489,000	4,120,000	521,000	548,000	432,000	20,318,000	405,000	148,000	11,000	1,031,000	29,000	572,000	13,000	27,000	187,000	80,000	67,000	179,000	151,000	56,000	1,000	329,000	131,000	49,000	15,000	495,000	481,000	8,000	87,000	171,000	16,000	3,000	11,000	94,000	27,000	3,000	0	-	-	-	-	3,000	22,000	30,000	52,000
Venezuela impairment of net monetary assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	246,000	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in operating assets and liabilities
666,000	112,000	-272,000	251,000	805,000	302,000	253,000	676,000	592,000	-72,000	366,000	554,000	797,000	1,216,000	-1,047,000	136,000	-189,000	-264,000	463,000	-609,000	-557,000	-507,000	-120,000	89,000	248,000	-359,000	601,000	-1,150,000	-60,000	-448,000	-422,000	179,000	277,000	-601,000	597,000	-613,000	23,000	-69,000	57,000	132,000	85,000	-270,000	-121,000	132,000	-186,000	15,000	141,000	-190,000	-42,000
Deferred income taxes – net and uncertain tax positions
-233,000	-333,000	-290,000	-329,000	-33,000	-187,000	-161,000	-268,000	-221,000	-1,598,000	-606,000	90,000	-217,000	412,000	-195,000	-151,000	-51,000	334,000	307,000	-214,000	-190,000	-3,000	-99,000	-63,000	-61,000	-714,000	-229,000	-337,000	-100,000	-187,000	-192,000	95,000	-406,000	-278,000	-48,000	-124,000	-50,000	-120,000	-85,000	6,000	0	-9,000	-23,000	-46,000	-62,000	155,000	24,000	-114,000	-40,000
Amortization of purchased intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	48,000
Stock-based compensation
30,000	20,000	35,000	30,000	34,000	33,000	45,000	47,000	30,000	27,000	31,000	35,000	40,000	41,000	31,000	28,000	24,000	31,000	26,000	31,000	29,000	34,000	18,000	26,000	17,000	22,000	17,000	7,000	18,000	21,000	20,000	21,000	20,000	22,000	22,000	24,000	23,000	21,000	18,000	23,000	18,000	13,000	16,000	16,000	9,000	17,000	17,000	17,000	12,000
Goodwill impairment
-	-	-	-	-	-	0	120,000	180,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of equity investment
-	-	-	-	-	-	9,000	0	94,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development in process
-	-	-	-	-	60,000	0	0	54,000	-	-	-	-	160,000	252,000	0	10,000	11,000	0	24,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,000	0	5,000	4,000	-	-	-	-	-	-	-	-
Other items
-	-	-	-	-	-	-	-60,000	16,000	-	25,000	-17,000	-17,000	160,000	-20,000	-119,000	-7,000	747,000	-647,000	-118,000	-128,000	-1,000	6,000	-9,000	-20,000	-5,000	-2,000	-37,000	-99,000	-45,000	-7,000	4,000	41,000	-42,000	-83,000	-11,000	33,000	-18,000	-52,000	37,000	-24,000	-	-	-40,000	8,000	-23,000	2,000	-29,000	-34,000
Net loss (gain) from sale of long-lived assets and investments
-24,000	28,000	-4,000	-8,000	2,000	-34,000	-35,000	-18,000	106,000	1,042,000	-17,000	26,000	39,000	33,000	710,000	21,000	0	-2,000	42,000	30,000	16,000	29,000	-10,000	5,000	-25,000	3,000	1,000	-25,000	3,000	-9,000	18,000	-7,000	1,000	-143,000	151,000	5,000	59,000	12,000	72,000	-53,000	24,000	-	-	-	-	-	-	-	-
Other items
2,000	-	-	-	83,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities
305,000	538,000	325,000	-227,000	112,000	367,000	421,000	162,000	1,496,000	859,000	795,000	435,000	136,000	90,000	1,461,000	963,000	1,376,000	1,615,000	1,093,000	1,480,000	1,354,000	1,752,000	1,424,000	1,053,000	898,000	816,000	444,000	875,000	1,102,000	1,577,000	1,048,000	1,191,000	756,000	1,428,000	482,000	1,324,000	900,000	1,102,000	1,194,000	954,000	886,000	957,000	1,025,000	658,000	733,000	969,000	710,000	806,000	746,000
Investing activities:
Beneficial interest collected in exchange for securitized accounts receivables
368,000	379,000	362,000	384,000	362,000	363,000	402,000	526,000	444,000	320,000	322,000	306,000	334,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property, plant and equipment
128,000	119,000	169,000	112,000	125,000	213,000	139,000	136,000	163,000	267,000	212,000	193,000	202,000	333,000	221,000	175,000	172,000	248,000	170,000	169,000	185,000	300,000	212,000	192,000	225,000	314,000	228,000	225,000	264,000	327,000	249,000	254,000	274,000	317,000	276,000	226,000	234,000	234,000	175,000	136,000	165,000	212,000	196,000	151,000	160,000	181,000	178,000	180,000	142,000
Proceeds from sale of long lived assets
6,000	174,000	35,000	123,000	11,000	10,000	39,000	17,000	824,000	1,870,000	122,000	73,000	1,412,000	202,000	1,761,000	37,000	2,000	16,000	73,000	353,000	82,000	39,000	15,000	124,000	18,000	14,000	23,000	7,000	143,000	64,000	67,000	7,000	126,000	104,000	34,000	56,000	85,000	41,000	74,000	517,000	68,000	123,000	106,000	12,000	30,000	621,000	870,000	534,000	1,356,000
Purchases of investments and other assets
-	-	-	-	-	63,000	0	0	56,000	6,000	180,000	8,000	6,000	165,000	279,000	8,000	29,000	77,000	-9,000	1,817,000	118,000	82,000	126,000	108,000	8,000	3,000	44,000	9,000	104,000	128,000	48,000	17,000	8,000	75,000	25,000	46,000	71,000	21,000	15,000	179,000	221,000	159,000	234,000	31,000	9,000	290,000	512,000	637,000	716,000
Other investing activities
-6,000	1,000	0	-35,000	-24,000	23,000	-45,000	1,000	10,000	5,000	-9,000	264,000	22,000	227,000	0	3,000	-18,000	-21,000	5,000	23,000	-2,000	4,000	5,000	11,000	10,000	13,000	11,000	39,000	41,000	18,000	19,000	18,000	38,000	2,000	13,000	24,000	10,000	13,000	22,000	13,000	10,000	15,000	12,000	5,000	3,000	23,000	-18,000	-45,000	-27,000
Acquisitions of subsidiaries, net of cash acquired
-	-	-	-	-	-	-	-	-	-	-	-	-	274,000	33,562,000	76,000	2,236,000	5,000	43,000	3,261,000	0	0	200,000	0	163,000	0	39,000	0	0	-	-	-	-	5,201,000	914,000	0	446,000	-11,000	4,962,000	0	0	-	-	-	-	3,983,000	352,000	4,000	410,000
Net cash provided by investing activities
252,000	430,000	224,000	429,000	272,000	74,000	347,000	406,000	1,039,000	1,912,000	104,000	-86,000	1,516,000	538,000	-32,301,000	-225,000	-2,417,000	-293,000	-136,000	-4,917,000	-219,000	-347,000	-528,000	-187,000	-388,000	-316,000	-299,000	-266,000	-266,000	-409,000	-249,000	-282,000	-194,000	-5,491,000	-1,194,000	-240,000	-676,000	-216,000	-5,100,000	189,000	-328,000	-263,000	-336,000	-175,000	-142,000	-3,856,000	-154,000	-242,000	115,000
Financing activities:
Redemption of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	814,000	0	0	45,000	0	-	-	-	-	-	-	-	-
Repayment of senior notes and loans and other long-term liabilities
700,000	2,229,000	1,558,000	31,000	126,000	457,000	700,000	46,000	6,243,000	-	-	-	-	949,000	7,000	2,000	41,000	44,000	9,000	1,010,000	1,458,000	42,000	12,000	18,000	767,000	1,128,000	23,000	220,000	1,762,000	1,029,000	30,000	1,093,000	61,000	531,000	208,000	-13,000	25,000	4,000	1,038,000	858,000	72,000	119,000	88,000	60,000	58,000	18,000	27,000	108,000	3,000
Proceeds from senior notes and loans, net of issuance costs
-	-	-	-	-	0	-1,000	-5,000	4,440,000	-	-	-	-	1,000	25,253,000	1,000	-3,000	-49,000	1,000	2,000	2,145,000	0	2,000	0	-2,000	336,000	2,000	0	0	-	-	-	-	-	-	-	-	-	-	-	-	140,000	28,000	9,000	268,000	35,000	1,000	1,000	2,000
Proceeds From Senior Notes Net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,975,000	0	0	748,000	-	-	-	0	-	-	-	-	-	-	-	-
Purchase of treasury shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	439,000	500,000	0	0	0	0	0	297,000	200,000	494,000	0	134,000	533,000	150,000	254,000	95,000	400,000	99,000	0	0	0	-	-	-	-	-	-	-	-
Net change in short-term debt
-	-	-	-	-	2,000	-1,000	0	-261,000	-53,000	-153,000	-127,000	-1,350,000	682,000	558,000	720,000	38,000	-1,519,000	-866,000	2,397,000	17,000	-13,000	-98,000	-610,000	336,000	384,000	-5,000	25,000	-20,000	22,000	-307,000	-2,350,000	143,000	-1,029,000	1,416,000	-409,000	-102,000	-345,000	987,000	2,000	-18,000	-1,852,000	-137,000	141,000	-154,000	191,000	-33,000	-291,000	163,000
Tax withholding payments made on shares and dividends
0	-	0	0	52,000	-	0	0	22,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax benefit on options exercised
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,000	0	6,000	10,000	11,000	3,000	9,000
Other financing activities
0	3,000	-1,000	-2,000	-11,000	-44,000	-3,000	-5,000	-5,000	-5,000	-48,000	-14,000	-7,000	-26,000	-41,000	-71,000	-31,000	-14,000	-10,000	-106,000	-48,000	10,000	-7,000	-4,000	-8,000	3,000	18,000	1,000	1,000	5,000	0	0	0	2,000	-1,000	1,000	3,000	3,000	1,000	2,000	8,000	-	-	-	-	-	-	-	-
Dividends paid on ordinary shares
-	-	-	-	-	-	-	-	-	87,000	123,000	345,000	346,000	346,000	340,000	310,000	307,000	290,000	287,000	288,000	290,000	272,000	294,000	299,000	291,000	276,000	264,000	268,000	281,000	214,000	237,000	230,000	174,000	190,000	204,000	203,000	203,000	172,000	167,000	164,000	165,000	142,000	126,000	134,000	127,000	89,000	97,000	106,000	95,000
Dividends paid on preferred shares
-	-	-	-	-	-	-	-	-	65,000	65,000	65,000	65,000	64,000	65,000	66,000	60,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of options by employees
-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	14,000	7,000	13,000	49,000	81,000	92,000	166,000	224,000	80,000	112,000	98,000	62,000	16,000	11,000	2,000	-10,000	5,000	7,000	12,000	16,000	24,000	8,000	23,000	43,000	12,000	53,000	72,000	46,000	49,000	33,000	41,000	86,000	61,000	9,000	36,000
Proceeds from issuance of ordinary shares, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	329,000	3,291,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of mandatory convertible preferred shares, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	329,000	3,291,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-700,000	-241,000	-1,461,000	-35,000	-189,000	-499,000	-705,000	-56,000	-2,091,000	-2,506,000	-825,000	-651,000	-1,768,000	-701,000	25,372,000	279,000	267,000	4,715,000	-1,090,000	1,087,000	93,000	-593,000	-329,000	-819,000	-634,000	-619,000	-256,000	-748,000	-2,260,000	266,000	-570,000	-761,000	-613,000	4,092,000	698,000	-684,000	-770,000	-573,000	-204,000	1,525,000	-175,000	-213,000	-897,000	-1,131,000	-24,000	1,963,000	-84,000	-633,000	112,000
Translation adjustment on cash and cash equivalents
-28,000	7,000	-12,000	25,000	-4,000	-35,000	-49,000	-69,000	11,000	18,000	7,000	1,000	28,000	-496,000	41,000	3,000	-208,000	-19,000	-7,000	22,000	-58,000	-59,000	-43,000	1,000	-13,000	9,000	14,000	-10,000	-61,000	13,000	15,000	-22,000	17,000	-18,000	-40,000	18,000	19,000	0	191,000	-170,000	-22,000	-84,000	45,000	59,000	-71,000	-76,000	-102,000	44,000	48,000
Net change in cash and cash equivalents
-171,000	734,000	-924,000	192,000	191,000	-93,000	14,000	443,000	455,000	283,000	81,000	-301,000	-88,000	-569,000	-5,427,000	1,020,000	-982,000	6,018,000	-140,000	-2,328,000	1,170,000	753,000	524,000	48,000	-137,000	-110,000	-97,000	-149,000	-1,485,000	1,447,000	244,000	126,000	-34,000	11,000	-54,000	418,000	-527,000	313,000	-3,919,000	2,498,000	361,000	397,000	-163,000	-589,000	496,000	-1,000,000	370,000	-25,000	1,021,000
Net change in operating assets and liabilities:
Decrease (increase) in working capital items
666,000	112,000	-272,000	251,000	805,000	302,000	253,000	676,000	592,000	-72,000	366,000	554,000	797,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	141,000	-190,000	-42,000